The majority of ALS studies are not stratified for genetic status, do not provide comprehensive screening for genetic variants, or only screen for a panel of the most common genetic variants associated with the disease (SOD1, C9orf72, TARDBP, FUS, etc.). This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.